Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis: an Open-label Extension Trial

NCT01955733 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01955733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01955733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis: an Open-label Extension Trial
Lead sponsor
Boehringer Ingelheim
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2013
Completion date
November 7, 2016
Enrollment
91 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid